HIV-associated neurocognitive impairment in the modern ART era

Are we close to discovering reliable biomarkers in the setting of virological suppression?

Alessandra Bandera, Lucia Taramasso, Giorgio Bozzi, Antonio Muscatello, Jake A. Robinson, Tricia H. Burdo, Andrea Gori

Research output: Contribution to journalReview article

Abstract

The prevalence of the most severe forms of HIV-associated neurocognitive disorders (HAND) is decreasing due to worldwide availability and high efficacy of antiretroviral treatment (ART). However, several grades of HIV-related cognitive impairment persist with effective ART and remain a clinical concern for people with HIV (PWH). The pathogenesis of these cognitive impairments has yet to be fully understood and probably multifactorial. In PWH with undetectable peripheral HIV-RNA, the presence of viral escapes in cerebrospinal fluid (CSF) might explain a proportion of cases, but not all. Many other mechanisms have been hypothesized to be involved in disease progression, in order to identify possible therapeutic targets. As potential indicators of disease staging and progression, numerous biomarkers have been used to characterize and implicate chronic inflammation in the pathogenesis of neuronal injuries, such as certain phenotypes of activated monocytes/macrophages, in the context of persistent immune activation. Despite none of them being disease-specific, the correlation of several CSF cellular biomarkers to HIV-induced neuronal damage has been investigated. Furthermore, recent studies have been evaluating specific microRNA (miRNA) profiles in the CSF of PWH with neurocognitive impairment (NCI). The aim of the present study is to review the body of evidence on different biomarkers use in research and clinical settings, focusing on PWH on ART with undetectable plasma HIV-RNA.

Original languageEnglish
Article number187
JournalFrontiers in Aging Neuroscience
Volume10
Issue numberJUL
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Biomarkers
HIV
Cerebrospinal Fluid
Disease Progression
Viral RNA
MicroRNAs
Monocytes
Macrophages
RNA
Inflammation
Phenotype
Wounds and Injuries
Research

Keywords

  • AIDS
  • ANI
  • Art
  • Dementia
  • HAND
  • HIV
  • Marker
  • Neurocognitive impairment

ASJC Scopus subject areas

  • Ageing
  • Cognitive Neuroscience

Cite this

HIV-associated neurocognitive impairment in the modern ART era : Are we close to discovering reliable biomarkers in the setting of virological suppression? / Bandera, Alessandra; Taramasso, Lucia; Bozzi, Giorgio; Muscatello, Antonio; Robinson, Jake A.; Burdo, Tricia H.; Gori, Andrea.

In: Frontiers in Aging Neuroscience, Vol. 10, No. JUL, 187, 01.01.2019.

Research output: Contribution to journalReview article

@article{b76ba6d879ab473eb0535f1cd1ce628a,
title = "HIV-associated neurocognitive impairment in the modern ART era: Are we close to discovering reliable biomarkers in the setting of virological suppression?",
abstract = "The prevalence of the most severe forms of HIV-associated neurocognitive disorders (HAND) is decreasing due to worldwide availability and high efficacy of antiretroviral treatment (ART). However, several grades of HIV-related cognitive impairment persist with effective ART and remain a clinical concern for people with HIV (PWH). The pathogenesis of these cognitive impairments has yet to be fully understood and probably multifactorial. In PWH with undetectable peripheral HIV-RNA, the presence of viral escapes in cerebrospinal fluid (CSF) might explain a proportion of cases, but not all. Many other mechanisms have been hypothesized to be involved in disease progression, in order to identify possible therapeutic targets. As potential indicators of disease staging and progression, numerous biomarkers have been used to characterize and implicate chronic inflammation in the pathogenesis of neuronal injuries, such as certain phenotypes of activated monocytes/macrophages, in the context of persistent immune activation. Despite none of them being disease-specific, the correlation of several CSF cellular biomarkers to HIV-induced neuronal damage has been investigated. Furthermore, recent studies have been evaluating specific microRNA (miRNA) profiles in the CSF of PWH with neurocognitive impairment (NCI). The aim of the present study is to review the body of evidence on different biomarkers use in research and clinical settings, focusing on PWH on ART with undetectable plasma HIV-RNA.",
keywords = "AIDS, ANI, Art, Dementia, HAND, HIV, Marker, Neurocognitive impairment",
author = "Alessandra Bandera and Lucia Taramasso and Giorgio Bozzi and Antonio Muscatello and Robinson, {Jake A.} and Burdo, {Tricia H.} and Andrea Gori",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fnagi.2019.00187",
language = "English",
volume = "10",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Research Foundation",
number = "JUL",

}

TY - JOUR

T1 - HIV-associated neurocognitive impairment in the modern ART era

T2 - Are we close to discovering reliable biomarkers in the setting of virological suppression?

AU - Bandera, Alessandra

AU - Taramasso, Lucia

AU - Bozzi, Giorgio

AU - Muscatello, Antonio

AU - Robinson, Jake A.

AU - Burdo, Tricia H.

AU - Gori, Andrea

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The prevalence of the most severe forms of HIV-associated neurocognitive disorders (HAND) is decreasing due to worldwide availability and high efficacy of antiretroviral treatment (ART). However, several grades of HIV-related cognitive impairment persist with effective ART and remain a clinical concern for people with HIV (PWH). The pathogenesis of these cognitive impairments has yet to be fully understood and probably multifactorial. In PWH with undetectable peripheral HIV-RNA, the presence of viral escapes in cerebrospinal fluid (CSF) might explain a proportion of cases, but not all. Many other mechanisms have been hypothesized to be involved in disease progression, in order to identify possible therapeutic targets. As potential indicators of disease staging and progression, numerous biomarkers have been used to characterize and implicate chronic inflammation in the pathogenesis of neuronal injuries, such as certain phenotypes of activated monocytes/macrophages, in the context of persistent immune activation. Despite none of them being disease-specific, the correlation of several CSF cellular biomarkers to HIV-induced neuronal damage has been investigated. Furthermore, recent studies have been evaluating specific microRNA (miRNA) profiles in the CSF of PWH with neurocognitive impairment (NCI). The aim of the present study is to review the body of evidence on different biomarkers use in research and clinical settings, focusing on PWH on ART with undetectable plasma HIV-RNA.

AB - The prevalence of the most severe forms of HIV-associated neurocognitive disorders (HAND) is decreasing due to worldwide availability and high efficacy of antiretroviral treatment (ART). However, several grades of HIV-related cognitive impairment persist with effective ART and remain a clinical concern for people with HIV (PWH). The pathogenesis of these cognitive impairments has yet to be fully understood and probably multifactorial. In PWH with undetectable peripheral HIV-RNA, the presence of viral escapes in cerebrospinal fluid (CSF) might explain a proportion of cases, but not all. Many other mechanisms have been hypothesized to be involved in disease progression, in order to identify possible therapeutic targets. As potential indicators of disease staging and progression, numerous biomarkers have been used to characterize and implicate chronic inflammation in the pathogenesis of neuronal injuries, such as certain phenotypes of activated monocytes/macrophages, in the context of persistent immune activation. Despite none of them being disease-specific, the correlation of several CSF cellular biomarkers to HIV-induced neuronal damage has been investigated. Furthermore, recent studies have been evaluating specific microRNA (miRNA) profiles in the CSF of PWH with neurocognitive impairment (NCI). The aim of the present study is to review the body of evidence on different biomarkers use in research and clinical settings, focusing on PWH on ART with undetectable plasma HIV-RNA.

KW - AIDS

KW - ANI

KW - Art

KW - Dementia

KW - HAND

KW - HIV

KW - Marker

KW - Neurocognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=85070613168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070613168&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2019.00187

DO - 10.3389/fnagi.2019.00187

M3 - Review article

VL - 10

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - JUL

M1 - 187

ER -